Kovitz Investment Group Partners’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.01M Sell
9,561
-608
-6% -$130K 0.04% 231
2026
Q1
$2.25M Hold
10,169
– – 0.05% 214
2025
Q4
$2.58M Sell
10,169
-2,622
-20% -$658K 0.06% 204
2025
Q3
$3.17M Buy
12,791
+11,202
+705% +$2.68M 0.01% 545
2025
Q2
$382K Buy
1,589
+182
+13% +$42.4K ﹤0.01% 1067
2025
Q1
$319K Buy
1,407
+95
+7% +$20.9K ﹤0.01% 1034
2024
Q4
$270K Buy
+1,312
New +$288K ﹤0.01% 1072

Other funds holding STE

Kovitz Investment Group Partners's STE Position: Q2 2026 in Review

Kovitz Investment Group Partners reduced its Steris (STE) stake by 6% in Q2 2026, selling an estimated $130K and leaving 9,561 shares worth $2.01M. The position accounts for 0.04% of the portfolio, ranked #231.

Kovitz Investment Group Partners first reported a position in STE in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.17M in Q3 2025. 839 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Kovitz Investment Group Partners held 9,561 shares of Steris worth $2.01M as of Q2 2026.
  • Kovitz Investment Group Partners sold 608 Steris shares in Q2 2026, an estimated $130K.
  • Steris made up 0.04% of Kovitz Investment Group Partners's portfolio in Q2 2026, its #231 holding.
  • Kovitz Investment Group Partners first reported a position in Steris in Q4 2024 and has held it in 7 quarters since.
  • Kovitz Investment Group Partners's Steris position peaked at $3.17M in Q3 2025.
  • 839 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Kovitz Investment Group Partners's 13F filing for Q2 2026, filed 12 Aug 2026.